Birdwatch Note Rating
2023-03-15 21:00:36 UTC - NOT_HELPFUL
Rated by Participant: 465A25A0B3A6F19E1F23364E06E2A2B22308B5B79490FB20075AECF4662AC080
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details